Business Summary
|
ActivBiotics, Inc. (ActivBiotics) is a biopharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of inflammatory diseases and bacterial infections. The Company's lead product candidate, Rifalazil, is an orally administered antibacterial agent, which is in a Phase III clinical trial for the treatment of intermittent claudication associated with peripheral arterial disease (PAD). Its second product candidate, M40403, is a small molecule that is designed to mimic the function of a naturally occurring enzyme, which plays a role in several inflammatory disease states. In December 2005, ActivBiotics acquired Metaphore Pharmaceuticals.
|
|
|